Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

PLRX

Pliant Therapeutics (PLRX)

Pliant Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PLRX
DatumZeitQuelleÜberschriftSymbolFirma
22/05/202400h50GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International ConferenceNASDAQ:PLRXPliant Therapeutics Inc
14/05/202413h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
14/05/202413h30GlobeNewswire Inc.Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
07/05/202414h00GlobeNewswire Inc.Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™NASDAQ:PLRXPliant Therapeutics Inc
06/05/202422h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLRXPliant Therapeutics Inc
06/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
06/05/202422h05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
06/05/202412h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
01/05/202414h00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
02/04/202414h00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
27/03/202415h23GlobeNewswire Inc.Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International ConferenceNASDAQ:PLRXPliant Therapeutics Inc
12/03/202412h30GlobeNewswire Inc.Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
27/02/202422h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLRXPliant Therapeutics Inc
27/02/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
27/02/202422h03GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
26/02/202414h00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:PLRXPliant Therapeutics Inc
15/02/202402h55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PLRXPliant Therapeutics Inc
14/02/202414h52Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PLRXPliant Therapeutics Inc
07/02/202414h00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
05/02/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
04/02/202421h29GlobeNewswire Inc.Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver FibrosisNASDAQ:PLRXPliant Therapeutics Inc
24/01/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
24/01/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
24/01/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
24/01/202422h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
19/01/202423h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
19/01/202423h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
19/01/202423h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
03/01/202414h00GlobeNewswire Inc.Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PLRXPliant Therapeutics Inc
13/11/202322h30GlobeNewswire Inc.Pliant Therapeutics Presentations at The Liver Meeting® 2023 Highlight Bexotegrast, an Inhibitor of αvß6 and αvß1 Integrins, in Primary Sclerosing CholangitisNASDAQ:PLRXPliant Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PLRX

Kürzlich von Ihnen besucht

Delayed Upgrade Clock